PillRx only · Ointment · Topical
Diflorasone Diacetate
Diflorasone Diacetate
2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US2 NDCs
2 active makers
2 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$2.208
Latest avg · Jul 22, 2026
-10%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
374
Rx · 2026 Q1
28K
Units dispensed
-24%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it2 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Rising Pharma Holdings, Inc. | unknown | 4 | SUPPLYING |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | unknown | 3 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jun 24, 2024RECALLRecall (Class III): Diflorasone Diacetate Ointment, USP, 0.05%, 60g tube, Rx only, Mfd. By: Lyne Laboratories, Inc., Brockton, MA 02301; Mf…
Failed Impurities/Degradation Specifications: The impurity results at 12 months stability testing,did not conform to the specification limit. — Recalling firm: Rising Pharma Holding, Inc. — Nationwide in the USA